Secukinumab belongs to a class of medicines called biologics. Biologics are genetically-engineered proteins. Secukinumab, a monoclonal antibody, works by blocking the activity of a protein called interleukin (IL) 17A. IL-17A levels are increased in diseases such as psoriasis, psoriatic arthritis and ankylosing spondylitis. Secukinumab, via blocking IL-17A, helps to reduce the activity of the immune system and the symptoms of the diseases.
Secukinumab is used to treat autoimmune diseases (disease where the body's natural defence system attacks own body cells). You are taking Secukinumab for (please tick as appropriate):
Other, please specify: ___________________________________
Subscribe to our mailing list to get the updates to your email inbox...